Compugen (CGEN) Shareholder's Equity Growth (3y) (2012 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.77% |
| Sep 30, 2025 | -18.11% |
| Jun 30, 2025 | -17.77% |
| Mar 31, 2025 | -16.52% |
| Dec 31, 2024 | -19.86% |
| Sep 30, 2024 | -15.09% |
| Jun 30, 2024 | -17.37% |
| Mar 31, 2024 | -18.65% |
| Dec 31, 2023 | -18.20% |
| Sep 30, 2023 | -25.21% |
| Jun 30, 2023 | -21.76% |
| Mar 31, 2023 | -15.35% |
| Dec 31, 2022 | 26.56% |
| Sep 30, 2022 | 24.00% |
| Jun 30, 2022 | 41.66% |
| Mar 31, 2022 | 43.41% |
| Dec 31, 2021 | 42.02% |
| Sep 30, 2021 | 37.32% |
| Jun 30, 2021 | 36.63% |
| Mar 31, 2021 | 53.91% |
| Dec 31, 2020 | 59.90% |
| Sep 30, 2020 | 49.61% |
| Jun 30, 2020 | 39.96% |
| Mar 31, 2020 | 26.96% |
| Dec 31, 2019 | -15.50% |
| Sep 30, 2019 | -15.89% |
| Jun 30, 2019 | -25.58% |
| Mar 31, 2019 | -26.23% |
| Dec 31, 2018 | -25.45% |
| Sep 30, 2018 | -24.70% |
| Jun 30, 2018 | -24.82% |
| Mar 31, 2018 | -32.97% |
| Dec 31, 2017 | -34.89% |
| Sep 30, 2017 | -29.03% |
| Jun 30, 2017 | -21.64% |
| Mar 31, 2017 | -17.67% |
| Dec 31, 2016 | 25.82% |
| Sep 30, 2016 | 37.56% |
| Jun 30, 2016 | 55.00% |
| Mar 31, 2016 | 56.19% |
| Dec 31, 2015 | 71.98% |
| Sep 30, 2015 | 68.49% |
| Jun 30, 2015 | 63.36% |
| Mar 31, 2015 | 68.10% |
| Dec 31, 2014 | 75.65% |
| Sep 30, 2014 | 68.55% |
| Jun 30, 2014 | 56.06% |
| Mar 31, 2014 | 54.85% |
| Dec 31, 2013 | 4.08% |
| Sep 30, 2013 | 0.21% |
| Jun 30, 2013 | -7.69% |
| Mar 31, 2013 | -8.74% |
| Dec 31, 2012 | -13.60% |
| Sep 30, 2012 | 25.78% |
| Jun 30, 2012 | 25.95% |
| Mar 31, 2012 | 33.63% |